Related Experiment Video
Updated: Aug 18, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Control of the G1/S transition
1Department of Molecular Biology, Scripps Research Institute, La Jolla, California 92037, USA.
Abstract:
On the basis of current knowledge, control of the G1/S phase transition is largely a matter of regulating a set of specific cyclin dependent kinase (CDK) activities. In mammalian cells, the G1/S specific CDK activities are composed of complexes between D type cyclins and either CDK4 or CDK6 and between cyclin E (and possibly cyclin A) and CDK2. A variety of internal and external signals regulate G1/S specific CDKs by modulating cyclin availability, the levels of CDK inhibitory proteins and the phosphorylation status of CDKs. Although much is now known about the regulation of G1/S specific CDKs, the only well characterized substrate to date is the retinoblastoma gene product, RB. Phosphorylation of RB by CDKs neutralizes its cell cycle inhibitory properties, allowing progression of G1 to S phase. Not surprisingly, many components of the cell cycle regulatory machinery, including CDKs, CDK inhibitors and CDK substrates, are important targets of mutations that lead to human malignancy.
Insights
Cell cycle progression relies on regulating cyclin dependent kinase (CDK) activity, particularly at the G1/S phase transition. Key substrates like the retinoblastoma protein (RB) are crucial, and their dysregulation contributes to cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The G1/S phase transition is a critical checkpoint in the mammalian cell cycle.
- Regulation of this transition is primarily mediated by cyclin dependent kinases (CDKs).
Purpose of the Study:
- To review the current understanding of G1/S phase transition control.
- To highlight the role of CDKs and their substrates in cell cycle regulation and malignancy.
Main Methods:
- Literature review of cell cycle regulation mechanisms.
- Analysis of CDK complexes and their substrates.
- Discussion of signaling pathways influencing CDK activity.
Main Results:
- G1/S specific CDK activity involves complexes of D-type cyclins with CDK4/CDK6 and Cyclin E/A with CDK2.
- Cellular signals modulate CDK activity via cyclin levels, inhibitors, and phosphorylation.
- The retinoblastoma protein (RB) is a key CDK substrate, neutralizing its inhibitory role in G1 to S phase progression.
Conclusions:
- Dysregulation of cell cycle regulators, including CDKs, inhibitors, and substrates, is implicated in human cancers.
- Understanding CDK regulation is vital for cancer research and therapeutic development.
Related Concept Videos
Negative Regulator Molecules
The Cell Cycle Control System
Inhibition of Cdk Activity
The Cell Cycle Control System
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...

